机译:汇集基因组筛查鉴定抗凋亡基因作为卵巢癌中化疗抗性的可靶向介质
Department of Medical Oncology Dana-Farber Cancer Institute;
Cancer Program;
Department of Medical Oncology Dana-Farber Cancer Institute;
Department of Medical Oncology Dana-Farber Cancer Institute;
Peter MacCallum Cancer Centre;
Cancer Program;
Genetic Perturbation Platform;
Genetic Perturbation Platform;
Genetic Perturbation Platform;
Cancer Program;
Cancer Program;
John B. Little Center for Radiation Sciences Department of Environmental Health Harvard T.H. Chan;
Department of Medical Oncology Dana-Farber Cancer Institute;
Cancer Program;
Department of Cell Biology Harvard Medical School;
Department of Medical Oncology Dana-Farber Cancer Institute;
Department of Medical Oncology Dana-Farber Cancer Institute;
Department of Medical Oncology Dana-Farber Cancer Institute;
Department of Medical Oncology Dana-Farber Cancer Institute;
Cancer Program;
Department of Medical Oncology Dana-Farber Cancer Institute;
Genetic Perturbation Platform;
Department of Medical Oncology Dana-Farber Cancer Institute;
Peter MacCallum Cancer Centre;
John B. Little Center for Radiation Sciences Department of Environmental Health Harvard T.H. Chan;
Department of Medical Oncology Dana-Farber Cancer Institute;
Eli Lilly and Company;
Cancer Program;
Department of Medical Oncology Dana-Farber Cancer Institute;
机译:汇集基因组筛查鉴定抗凋亡基因作为卵巢癌中化疗抗性的可靶向介质
机译:整合基因组分析可识别介导上皮性卵巢癌遗传风险的表观遗传标记
机译:与多药耐药性相关的基因的慢病毒短发夹RNA筛选将PRP-4鉴定为人类卵巢癌化学耐药性的新调节剂。
机译:通过综合卵巢癌基因组学数据识别候选司机基因
机译:整合基因组学和分子生物学:鉴定前列腺癌致癌基因SOX4的转录靶标并评估Aurora激酶抑制作用对化疗耐药的卵巢癌的疗效
机译:化学遗传学筛选确定靶向抗凋亡蛋白用于癌症治疗的激酶抑制剂组合。
机译:具有汇集ShRNA文库的功能基因组学筛网和基因表达分析,与Azadirachta Indica提取物鉴定头部和颈部鳞状细胞癌治疗靶标的潜在途径
机译:综合功能基因组学和蛋白质组学揭示卵巢癌化疗耐药机制。